metastatic growth has obvious limitations. These growths can be cultured, both in vitro and in vivo, so immunotherapy opens up a new field.
In the third category are those patients with locally advanced carcinoma but still apparently free from disseminated growth. Heroic surgery has proved to be well worth while in many ofthese patients, but is surgery alone all that we can do, or should we consider adjuvant therapy? There is a good case for irradiating known and carefully marked residual tumour after resection of the bulk of the primary growth. Conversely, is radiotherapy alone ever adequate for these locally advanced growths, or should irradiated residual tumour be resected ?
Finally, in the fourth category are patients with both locally advanced primary growth and extensive dissemination. Too many of these patients are abandoned; with a combination of surgery, radiotherapy, chemotherapy and immunotherapy, some could be given a worthwhile prolongation of good quality life. It requires fine clinical judgment to decide just how far to go and when to cry halt.
Until recently the treatment of colorectal cancer has been regarded as surgical, but humility has been thrust upon us by realistic reviews of the results of our labours over the past fifty and more years. Clearly, there is a need for a multidisciplinary approach to this challenge: joint consultation before treatment is started and close collaboration throughout the management of each patient. Radiotherapy may be used in the management of cancer of the rectum for a variety of reasons. These include treatment of the primary disease as an adjunct to surgical therapy,+ of residual disease after surgery, and of recurrent or metastatic disease. This paper is solely concerned with the adjuvant use of radiotherapy as a post, operative measure.
The value of preoperative radiotherapy has been advocated in several clinical situations and has been reviewed on a theoretical and experimental basis on several recent occasions, for instance by Nias (1967), Powers & Palmer (1968) , Nickson & Glicksman (1972) and Scott (1973) . The possible advantages of adding irradiation before surgery in the management of a malignant tumour include a reduction in the size of the primary tumour, permitting easier resection, and reduced viability of the tumour cells at the time of operation. The latter effect should reduce the incidence of recurrence due to local and distant seeding of tumour during operative handling. Possible disadvantages include delay in operation, impaired surgical healing, incomplete surgical staging before treatment is initiated, and an adverse host-tumour response.
The main studies reported in the literature have been reviewed by Higgins & Dwight (1972) . Interest in this topic was raised by the report of Quan et al. (1960) on a retrospective study of 1276 patients. An improvement was observed in the five-year survival rate for those patients with involved pelvic lymph nodes from 23 % for surgery alone to 37% for those receiving preoperative radiation. These results based on a retrospective non-randomized survey have given rise to several new controlled studies.
A subsequent group of patients from the New York Memorial Hospital treated on a randomized study did not confirm these findings (Stearns et al. 1968 ). Further randomized studies have been initiated by a group at Yale (Kligerman et al. 1972) and the Veterans Administration Hospitals (Higgins & Dwight 1972) . The latter study has entered enough patients to yield early results which are in favour of radiotherapy when it is followed by an abdominoperineal excision.
Other observations of interest have emerged from the Memorial and Veterans Administration Studies. In these two series there has been a significant decrease in the number of lymph nodes found to be involved by tumour at the time of operation, when compared with the control incidence. No disadvantage! has been observed in the irradiated groups in respect of postoperative mortality and morbidity. In view of the contradictory findings of the two main randomized series, it is suggested that there is a need for further such studies. Before discussing the conservative treatment of early rectal cancers by irradiation, the phrase 'early cancer', as used in this paper, must be defined. As the treatment is not surgical this definition is based not on pathological study of operation specimens but on clinical data only. It includes invasive carcinomas with an unequivocal, histological protocol, and those which are clinically limited and slightly infiltrating.
Rectal cancer is generally considered to be only slightly radiosensitive, because of the rather bad results obtained from external irradiation applied to advanced rectal cancers or to local recurrences after amputation. This does not, however, apply to the treatment of early rectal carcinomas by endocavitary irradiation, using contact X-ray therapy either alone, or in combination with interstititial curietherapy by radium or iridium. It may seem surprising that an adenocarcinoma, known to be rather radioresistant if treated by a classical technique of irradiation, becomes very radiosensitive and radiocurable if treated by another technique. But the radiobiological features, i.e. the dose-time and dose-volume relationships, of the two techniques are quite different.
In external irradiation with cobalt 60, a dose of 4000 rad is necessarily applied to a very large volume of tissue, including an important part of the pelvic area. It cannot be delivered in less than 4 weeks. In endocavitary irradiation, a dose of 4000 R is given in 3 minutes (contact X-ray therapy) or a dose of 4000 rad is given in 3 days (interstitial curie-therapy) on a small target volume, not exceeding a few cubic centimetres. This is why endocavitary irradiation has a special efficacy for the limited rectal cancers.
Technique ofContact X-ray Therapy The machine used (Philips) has the following characteristics: low voltage (50 kV); short focal distance (4 cm); high output (1500-2000 R/min in the air); important absorption of the X-ray beam in the first 2 cm; narrow, light tube, easy to handle, and capable of being introduced in a special rectoscope.
The operator holds the X-ray tube in the right hand and the rectoscope in the left. He can at any time withdraw the tube and check the position of the field of irradiation, which is circular (diameter 3 cm). It is possible to use two overlapping fields.
A small number (3-5) of short applications (2-4 minutes) are given during an overall treatment time of 4-6 weeks. The treatment is carried out in the outpatient department and is compatible with normal active life. It is easily applicable in elderly or fragile patients.
The high dose of radiation given at every application (2500-4000 R) produces a rapid shrinkage of the exophytic part of the tumour. Hence at the second and third applications the tumour has a greatly reduced volume. The dose at every sitting, the size of the field and the intervals between each application are calculated in relation to the speed of shrinkage of the tumour (Papillon 1970) .
Technique ofInterstitial Curietherapy This is essentially applied to the residual lesion, or to the bed of the tumour after completion of contact X-ray therapy. Radium implant is made in the knee-chest position without general anmsthesia. Needles 4 cm in length are not sutured to the rectal wall but kept in place by a rubber drain pushed through the anus and fixed to the skin of the external margin. A dose of 2000-3000 rad is usually delivered in two or three days. Admission to hospital is necessary and anticoagulation treatment is systematically applied in order to prevent thromboembolism.
Neither of these techniques necessitates colostomy or anesthesia. The rectal wall tolerates endocavitary irradiation very well if the technique is good and the given dose normal. After completion of treatment there is often a very mild proctitis for two or three weeks. Afterwards the
